REFERENCES
  1. Spector, Jesse I. et al. “Sweet’s Syndrome: Association With Acute Leukemia.” JAMA  244 (1980): 1131-1132.
  2. Kazmi SM, Pemmaraju N, Patel KP, et al. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk . 2015;15(6):358-363. 10.1016/j.clml.2014.12.009
  3. Elgarten CW, Aplenc R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr . 2020;32(1):57-66. 10.1097/MOP.0000000000000855
  4. Lonetti A, Pession A, Masetti R. Targeted Therapies for Pediatric AML: Gaps and Perspective. Front Pediatr . 2019;7:463. Published 2019 Nov 15. 10.3389/fped.2019.00463
  5. Halpern J, Salim A. Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol . 2009;26(4):452-457. 10.1111/j.1525-1470.2009.00952.x
  6. Cohen PR. Sweet’s syndrome–a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis . 2007;2:34. Published 2007 Jul 26. 10.1186/1750-1172-2-34
  7. El-Khalawany M, Aboeldahab S, Mosbeh AS, Thabet A. Clinicopathologic, immunophenotyping and cytogenetic analysis of Sweet syndrome in Egyptian patients with acute myeloid leukemia. Pathol Res Pract . 2017;213(2):143-153. 10.1016/j.prp.2016.10.008
  8. Alegría-Landa V, Rodríguez-Pinilla SM, Santos-Briz A, et al. Clinicopathologic, Immunohistochemical, and Molecular Features of Histiocytoid Sweet Syndrome. JAMA Dermatol . 2017;153(7):651-659. 10.1001/jamadermatol.2016.6092
  9. Maller B, Bigness A, Moiño D, Greene J. Sweet’s syndrome associated with hematological malignancies. Leuk Res . 2020;99:106461. 10.1016/j.leukres.2020.106461
  10. Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol . 2013;68(6):1006-1015. 10.1016/j.jaad.2012.12.954
  11. Passet M, Lepelletier C, Vignon-Pennamen MD, et al. Next-Generation Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome Demonstrates Clonal Relation between Malignant Cells and Skin-Infiltrating Neutrophils. J Invest Dermatol . 2020;140(9):1873-1876.e5. 10.1016/j.jid.2019.12.040
  12. Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol . 1999;40(6 Pt 1):966-978. 10.1016/s0190-9622(99)70086-1
  13. Behm FG, Kay S, Aportela R. Febrile neutrophilic dermatosis associated with acute leukemia. Am J Clin Pathol . 1981;76(3):344-347. 10.1093/ajcp/76.3.344
  14. Paul S, Jammal N, Akhave N, et al. Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia. Br J Haematol . 2020;191(1):e10-e13. doi:10.1111/bjh.16937
  15. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol . 1988;6(12):1887-1897. 10.1200/JCO.1988.6.12.1887
LEGENDS
Figure 1: A) Diffuse erythematous, raised, tender papules and plaques distributed over arms and hands. B) Histopathology of the biopsy showed mildly spongiotic epidermis with an occasional necrotic keratinocyte[arrow] overlying an oedematous dermis with a prominent neutrophilic infiltrate[arrow head].